Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services announced a strategic collaboration under which Piramal will refer applicable customers seeking ADC manufacturing technology to Aji Bio-Pharma and AJICAP™. Aji Bio-Pharma will refer Piramal ...
read more
Wednesday, April 15, 2026
WuXi Biologics has obtained ISO 13485:2016 Medical Device Quality Management System certification, following an on-site audit that concluded with zero non-conformities.
read more
Wednesday, April 15, 2026
FUJIFILM Biotechnologies announced the opening of its new, 2,000 square meter (m2) quality control (QC) laboratory at its Hillerød, Denmark, commercial scale manufacturing site.
read more
Wednesday, April 15, 2026
Aragen has launched ChemiSHE, a first-of-its-kind chemistry synthesis laboratory in India, entirely operated and led by women scientists. The lab was inaugurated on 8 April 2026 at Aragen’s Mallapur campus in Hyderabad.
read more
Wednesday, April 15, 2026
Ardena announced that its new GLP bioanalytical laboratory in Somerset, New Jersey, is now operational and supporting client studies.
read more
Kincell Bio announced a significant strategic investment to expand and strengthen its Research Triangle Park (RTP), North Carolina facility. The expansion reinforces Kincell Bio's commitment to supporting clients as they advance from late-stage ...
read more
Clarity Pharmaceuticals announced the signing of a Commercial Manufacturing Agreement for 64Cu-SAR-bisPSMA with Nucleus RadioPharma.
read more
Andelyn Biosciences announced a partnership with Evolyra Therapeutics to manufacture clinical-grade AAV gene therapies for treating types 2C and 2D Limb-Girdle Muscular Dystrophies (LGMDs).
read more
Apotex announced that it has secured a sterile filling partnership with Halo Pharmaceuticals through an investment that provides Apotex with access to a significant portion of the overall sterile injectable filling capacity currently being installed ...
read more
Clinilabs announced it has successfully completed an inspection by the FDA with no observations.
read more
Vetter announced significant progress in the continued expansion of its global clinical manufacturing network. With the ongoing scale-up of its Vetter Development Service offering, the company is taking important steps to provide necessary capacity, ...
read more
Thermo Fisher Scientific announced a strategic data collaboration with HealthVerity to enhance data-driven clinical development and evidence generation for biopharma sponsors.
read more
Cartherics Pty Ltd and Catalent have signed an amended commercial license agreement enabling the use of a Catalent cGMP compliant induced pluripotent stem cells (iPSC) line for the manufacture and commercialization of Cartherics’ iPSC-derived ...
read more
Oncodesign Services has extended its collaboration with GIP ARRONAX to secure access to astatine-211 (At-211) as well as other radionuclides used in targeted radiotherapy (TRT), supporting the advancement of discovery and preclinical programs.
read more
Altruist Biologics, an Innovent Biologics subsidiary and contract development and manufacturing organization (CDMO), announced that its Hangzhou facility was granted the Drug Product Manufacturing License (C Certificate) from the Chinese National ...
read more